LAWRENCE, Mass.--(BUSINESS WIRE)--Nexcelom Bioscience LLC, provider of innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced it continues to ...

Nexcelom Bioscience LLC, provider of innovative devices and instruments for cell-based assays in cancer research and drug discovery, today announced a major enhancement — the addition of ...

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing Nexcelom is a leading, ...

Expertise in Automated Cell Counting and Analysis In 2003, the founders of Nexcelom introduced the CP2, a convenient tool to assist with manual cell counting. According to Dr. Jean Qiu, founder and ...

Ampersand Capital Partners has sold Nexcelom Bioscience to PerkinElmer for $260 million. Based in Lawrence, Massachusetts, Nexcelom is a provider of automated cell counting solutions. WELLESLEY, Mass.

Nexcelom Bioscience LLC has announced it has extended its product platform with the launch of the Cellometer Auto M10™ automatic cell counter. The Auto M10 maintains the user benefits of the ...

Nexcelom Bioscience is a biotechnology company composed of biological scientists, software developers, and mechanical engineers who are dedicated to advancing the field of biomedical research. It is a ...